With over 15 years of pioneering experience in the highly potent compounds and bioconjugation landscape, CARBOGEN AMCIS has a proven track record of delivering high-quality bio-conjugate and GMP Antibody Drug Conjugate (ADC) projects. Our journey in ADC began in 2005, and since then, we have become a trusted partner for customers ranging from small biotech firms to large pharmaceutical companies.

At the heart of our services is our state-of-the-art dedicated cGMP bioconjugation facility and development laboratories, operated by a committed team of experts. We specialize in conceptualizing and delivering the best bioconjugation strategies and high-quality bioconjugate products to meet your unique needs.

Our comprehensive BDS ADC services are strengthened by our drug-linker development and GMP manufacturing capabilities, as well as formulation and drug-product (DP) fill-and-finish expertise, providing a seamless end-to-end solution to rapidly advance your New Chemical Entities (NCE).

• Process and Analytical Technology Transfer/Development/Validation: Leveraging our extensive experience, we ensure the smooth transfer, development, and validation of your processes and analytical technologies.
• Bio-conjugate / ADC GMP Manufacturing: Our facility is equipped to handle GMP manufacturing under bioburden-controlled conditions for BDS and sterile conditions for DP, ensuring the highest standards of quality and compliance.
• Stability Study Services: We offer robust ICH-compliant stability study services to monitor the shelf-life and efficacy of your products over time.

Choose CARBOGEN AMCIS to drive your bioconjugation and ADC projects forward with confidence. Let our expertise and state-of-the-art facilities support your goals and accelerate your path to success.